Skip to content

Comparison of Liposomal Bupivacaine and Ropivacaine for Postoperative Pain Relief in Thoracoscopic Surgery with Different Nerve Block Techniques: A Blinded 2 × 2 Factorial Randomized Trial

Comparison of Liposomal Bupivacaine and Ropivacaine for Postoperative Pain Relief in Thoracoscopic Surgery with Different Nerve Block Techniques: A Blinded 2 × 2 Factorial Randomized Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112075
Enrollment
Unknown
Registered
2025-11-10
Start date
2025-11-17
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Paravertebral Block+Liposomal Bupivacaine (PVB+LB):After anesthesia induction, the patient was placed in the lateral position. Under aseptic conditions, a linear ultrasound probe was placed in the par
Paravertebral Block+Ropivacaine (PVB+R):After anesthesia induction, the patient was positioned laterally. Under ultrasound guidance and sterile preparation, a linear probe was placed in the parasagitt
after pleural movement was seen with a small test dose, the remaining local anesthetic was injected. Each level was injected with 5mL of 0.5% ropivacaine, totaling 20mL
Intercostal Nerve Block+Liposomal Bupivacaine (INB+LB):After anesthesia induction and lateral positioning, the surgeon created a 3 cm incision for thoracoscopy. Under thoracoscopic visualization, a 22
Intercostal Nerve Block+Ropivacaine (INB+R):Aft

Sponsors

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 18 and 75 years, regardless of gender; 2. Scheduled for elective thoracoscopic pulmonary surgery in the Department of Thoracic Surgery; 3. Able to cooperate with interviews and complete scale assessments; 4. Classified as American Society of Anesthesiologists (ASA) physical status I–III; 5. Provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. History of ipsilateral breast surgery; 2. Allergic to local anesthetics or have contraindications; 3. Contraindications to paravertebral or intercostal nerve block puncture; 4. Body mass index (BMI) > 35 kg/m^2; 5. Suffering from mental disorders, intellectual disabilities, epilepsy, or similar conditions; 6. Severe heart or lung disorders and liver or kidney dysfunction; 7. History of chronic chest pain; 8. History of drug abuse, substance abuse, or alcoholism; 9. Pregnant or breastfeeding women; 10. Participation in other clinical studies recently.

Design outcomes

Primary

MeasureTime frame
Brief Pain Inventory (BPI)–Worst pain intensity within 24 hours after surgery;Neuropathic pain (DN4);

Secondary

MeasureTime frame
BPI pain scores at other time points 3 days postoperatively;Consumption of analgesic drugs;Duration of blockade;Patient satisfaction with pain relief;Perioperative complications;Rescue analgesic doses;length of hospital stay;Chest tube removal time;Time to first ambulation;Symptom burden (MDASI-LC) Score;Quality of life (EQ-5D-5L) Score;

Countries

China

Contacts

Public ContactFeng Gao

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Qiaokou District, Wuhan City, Hubei Province

fgao@tjh.tjmu.edu.cn+86 139 7158 7381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026